Megan M. Davis

机构：California University of Pennsylvania · ORCID：0000-0003-4221-7876

发表论文 87 篇 · 总被引 8474 次 · h-index 27

代表论文

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells (2023 · Immunity · 被引 178)
Two cases of severe pulmonary toxicity from highly active mesothelin-directed CAR T cells (2023 · Molecular Therapy · 被引 98)
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies (2025 · Nature Medicine · 被引 75)
Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors (2023 · Cell Reports Medicine · 被引 67)
Quadruple adenine base–edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease–engineered T cells (2025 · Proceedings of the National Academy of Sciences · 被引 26)
Safety and efficacy of armored huCART19-IL18 in patients with relapsed/refractory lymphomas that progressed after anti-CD19 CAR T cells. (2024 · Journal of Clinical Oncology · 被引 18)